Skip to main content
Top
Published in: Critical Care 6/2014

Open Access 01-12-2014 | Research

Increased plasma levels of endozepines, endogenous ligands of benzodiazepine receptors, during systemic inflammation: a prospective observational study

Authors: Thomas Clavier, Marie-Christine Tonon, Anne Foutel, Emmanuel Besnier, Antoine Lefevre-Scelles, Fabrice Morin, Pierrick Gandolfo, Jean-Jacques Tuech, Muriel Quillard, Benoit Veber, Bertrand Dureuil, Hélène Castel, Vincent Compère

Published in: Critical Care | Issue 6/2014

Login to get access

Abstract

Introduction

Recent work has shown that benzodiazepines interact with the immune system and exhibit anti-inflammatory effects. By using in vitro models, researchers in several studies have shown that the peptidergic endogenous ligands of benzodiazepine receptors, named endozepines, are involved in the immune response. All endozepines identified so far derive from diazepam-binding inhibitor (DBI), which generates several biologically active fragments. The aim of the present study was to measure plasma levels of DBI-like immunoreactivity (DBI-LI) in a rat model of sepsis and in patients with systemic inflammation from septic or non-septic origin.

Methods

Cecal ligation and puncture (CLP) or sham surgery was performed in rats. Blood samples were taken from animals, patients hospitalized for digestive surgery with inflammatory diseases, and healthy volunteers. Measurements of plasma DBI-related peptides were carried out by radioimmunoassay in animal and human samples.

Results

In the rats, CLP provoked an increase of plasma DBI-LI (+37%) 6 hours postsurgery. In humans, DBI-LI levels were significantly higher in the systemic inflammation group than in the healthy volunteer group (48.6 (32.7 to 77.7) pg/ml versus 11.1 (5.9 to 35.3) pg/ml, P < 0.001). We found a positive correlation between endozepine levels and Acute Physiology and Chronic Health Evaluation II score (r s = 0.33 (0.026 to 0.58), P < 0.05) and tumor necrosis factor α levels (r s = 0.43 (0.14 to 0.65), P < 0.01). The area under the receiver operating characteristic curve for endozepines was 0.842 (95% CI (0.717 to 0.966), P < 0.0001) for discriminating patients with inflammation from healthy volunteers.

Conclusions

Endozepines might be involved in the inflammatory response in patients with systemic inflammation.
Appendix
Available only for authorised users
Literature
1.
go back to reference Martin J, Franck M, Fischer M, Spies C: Sedation and analgesia in German intensive care units: How is it done in reality? Results of a patient-based survey of analgesia and sedation. Intensive Care Med. 2006, 32: 1137-1142. 10.1007/s00134-006-0214-6.CrossRef Martin J, Franck M, Fischer M, Spies C: Sedation and analgesia in German intensive care units: How is it done in reality? Results of a patient-based survey of analgesia and sedation. Intensive Care Med. 2006, 32: 1137-1142. 10.1007/s00134-006-0214-6.CrossRef
2.
go back to reference Galdiero F, Bentivoglio C, Nuzzo I, Ianniello R, Capasso C, Mattera S, Nazzaro C, Galdiero M, Romano Carratelli C: Effects of benzodiazepines on immunodeficiency and resistance in mice. Life Sci. 1995, 57: 2413-2423. 10.1016/0024-3205(95)02199-0.CrossRef Galdiero F, Bentivoglio C, Nuzzo I, Ianniello R, Capasso C, Mattera S, Nazzaro C, Galdiero M, Romano Carratelli C: Effects of benzodiazepines on immunodeficiency and resistance in mice. Life Sci. 1995, 57: 2413-2423. 10.1016/0024-3205(95)02199-0.CrossRef
3.
go back to reference Pandharipande PP, Sanders RD, Girard TD, McGrane S, Thompson JL, Shintani AK, Herr DL, Maze M, Ely EW, MENDS investigators: Effect of dexmedetomidine versus lorazepam on outcome in patients with sepsis: an a priori-designed analysis of the MENDS randomized controlled trial. Crit Care. 2010, 14: R38-10.1186/cc8916.CrossRef Pandharipande PP, Sanders RD, Girard TD, McGrane S, Thompson JL, Shintani AK, Herr DL, Maze M, Ely EW, MENDS investigators: Effect of dexmedetomidine versus lorazepam on outcome in patients with sepsis: an a priori-designed analysis of the MENDS randomized controlled trial. Crit Care. 2010, 14: R38-10.1186/cc8916.CrossRef
4.
go back to reference Kim SN, Son SC, Lee SM, Kim CS, Yoo DG, Lee SK, Hur GM, Park JB, Jeon BH: Midazolam inhibits proinflammatory mediators in the lipopolysaccharide-activated macrophage. Anesthesiology. 2006, 105: 105-110. 10.1097/00000542-200607000-00019.CrossRef Kim SN, Son SC, Lee SM, Kim CS, Yoo DG, Lee SK, Hur GM, Park JB, Jeon BH: Midazolam inhibits proinflammatory mediators in the lipopolysaccharide-activated macrophage. Anesthesiology. 2006, 105: 105-110. 10.1097/00000542-200607000-00019.CrossRef
5.
go back to reference Sigel E, Steinmann ME: Structure, function, and modulation of GABAA receptors. J Biol Chem. 2012, 287: 40224-40231. 10.1074/jbc.R112.386664.CrossRef Sigel E, Steinmann ME: Structure, function, and modulation of GABAA receptors. J Biol Chem. 2012, 287: 40224-40231. 10.1074/jbc.R112.386664.CrossRef
6.
go back to reference Papadopoulos V, Baraldi M, Guilarte TR, Knudsen TB, Lacapère JJ, Lindemann P, Norenberg MD, Nutt D, Weizman A, Zhang MR, Gavish M: Translocator protein (18 kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function. Trends Pharmacol Sci. 2006, 27: 402-409. 10.1016/j.tips.2006.06.005.CrossRef Papadopoulos V, Baraldi M, Guilarte TR, Knudsen TB, Lacapère JJ, Lindemann P, Norenberg MD, Nutt D, Weizman A, Zhang MR, Gavish M: Translocator protein (18 kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function. Trends Pharmacol Sci. 2006, 27: 402-409. 10.1016/j.tips.2006.06.005.CrossRef
7.
go back to reference Veenman L, Gavish M: The peripheral-type benzodiazepine receptor and the cardiovascular system. Implications for drug development. Pharmacol Ther. 2006, 110: 503-524. 10.1016/j.pharmthera.2005.09.007.CrossRef Veenman L, Gavish M: The peripheral-type benzodiazepine receptor and the cardiovascular system. Implications for drug development. Pharmacol Ther. 2006, 110: 503-524. 10.1016/j.pharmthera.2005.09.007.CrossRef
8.
go back to reference Krueger KE: Molecular and functional properties of mitochondrial benzodiazepine receptors. Biochim Biophys Acta. 1995, 1241: 453-470. 10.1016/0304-4157(95)00016-X.CrossRef Krueger KE: Molecular and functional properties of mitochondrial benzodiazepine receptors. Biochim Biophys Acta. 1995, 1241: 453-470. 10.1016/0304-4157(95)00016-X.CrossRef
9.
go back to reference Guidotti A, Forchetti CM, Corda MG, Konkel D, Bennett CD, Costa E: Isolation, characterization, and purification to homogeneity of an endogenous polypeptide with agonistic action on benzodiazepine receptors. Proc Natl Acad Sci U S A. 1983, 80: 3531-3535. 10.1073/pnas.80.11.3531.CrossRef Guidotti A, Forchetti CM, Corda MG, Konkel D, Bennett CD, Costa E: Isolation, characterization, and purification to homogeneity of an endogenous polypeptide with agonistic action on benzodiazepine receptors. Proc Natl Acad Sci U S A. 1983, 80: 3531-3535. 10.1073/pnas.80.11.3531.CrossRef
10.
go back to reference Ferrero P, Santi MR, Conti-Tronconi B, Costa E, Guidotti A: Study of an octadecaneuropeptide derived from diazepam binding inhibitor (DBI): biological activity and presence in rat brain. Proc Natl Acad Sci U S A. 1986, 83: 827-831. 10.1073/pnas.83.3.827.CrossRef Ferrero P, Santi MR, Conti-Tronconi B, Costa E, Guidotti A: Study of an octadecaneuropeptide derived from diazepam binding inhibitor (DBI): biological activity and presence in rat brain. Proc Natl Acad Sci U S A. 1986, 83: 827-831. 10.1073/pnas.83.3.827.CrossRef
11.
go back to reference Papadopoulos V, Berkovich A, Krueger KE, Costa E, Guidotti A: Diazepam binding inhibitor and its processing products stimulate mitochondrial steroid biosynthesis via an interaction with mitochondrial benzodiazepine receptors. Endocrinology. 1991, 129: 1481-1488. 10.1210/endo-129-3-1481.CrossRef Papadopoulos V, Berkovich A, Krueger KE, Costa E, Guidotti A: Diazepam binding inhibitor and its processing products stimulate mitochondrial steroid biosynthesis via an interaction with mitochondrial benzodiazepine receptors. Endocrinology. 1991, 129: 1481-1488. 10.1210/endo-129-3-1481.CrossRef
12.
go back to reference Ferrarese C, Perego M, Marzorati C, Bianchi G, Frigo M, Pecora N, Riva R, Moretti G, Frattola L: Modifications of diazepam binding inhibitor and peripheral benzodiazepine receptors in the lymphocytes of epileptic patients. Ital J Neurol Sci. 1996, 17: 141-145. 10.1007/BF02000845.CrossRef Ferrarese C, Perego M, Marzorati C, Bianchi G, Frigo M, Pecora N, Riva R, Moretti G, Frattola L: Modifications of diazepam binding inhibitor and peripheral benzodiazepine receptors in the lymphocytes of epileptic patients. Ital J Neurol Sci. 1996, 17: 141-145. 10.1007/BF02000845.CrossRef
13.
go back to reference Rocca P, Bellone G, Benna P, Bergamasco B, Ravizza L, Ferrero P: Peripheral-type benzodiazepine receptors and diazepam binding inhibitor-like immunoreactivity distribution in human peripheral blood mononuclear cells. Immunopharmacology. 1993, 25: 163-178. 10.1016/0162-3109(93)90018-L.CrossRef Rocca P, Bellone G, Benna P, Bergamasco B, Ravizza L, Ferrero P: Peripheral-type benzodiazepine receptors and diazepam binding inhibitor-like immunoreactivity distribution in human peripheral blood mononuclear cells. Immunopharmacology. 1993, 25: 163-178. 10.1016/0162-3109(93)90018-L.CrossRef
14.
go back to reference Taupin V, Herbelin A, Descamps-Latscha B, Zavala F: Endogenous anxiogenic peptide, ODN-diazepam-binding inhibitor, and benzodiazepines enhance the production of interleukin-1 and tumor necrosis factor by human monocytes. Lymphokine Cytokine Res. 1991, 10: 7-13. Taupin V, Herbelin A, Descamps-Latscha B, Zavala F: Endogenous anxiogenic peptide, ODN-diazepam-binding inhibitor, and benzodiazepines enhance the production of interleukin-1 and tumor necrosis factor by human monocytes. Lymphokine Cytokine Res. 1991, 10: 7-13.
15.
go back to reference Stepień H, Agro A, Crossley J, Padol I, Richards C, Stanisz A: Immunomodulatory properties of diazepam-binding inhibitor: effect on human interleukin-6 secretion, lymphocyte proliferation and natural killer cell activity in vitro. Neuropeptides. 1993, 25: 207-211. 10.1016/0143-4179(93)90104-I.CrossRef Stepień H, Agro A, Crossley J, Padol I, Richards C, Stanisz A: Immunomodulatory properties of diazepam-binding inhibitor: effect on human interleukin-6 secretion, lymphocyte proliferation and natural killer cell activity in vitro. Neuropeptides. 1993, 25: 207-211. 10.1016/0143-4179(93)90104-I.CrossRef
16.
go back to reference Cosentino M, Marino F, Cattaneo S, Di Grazia L, Francioli C, Fietta AM, Lecchini S, Frigo G: Diazepam-binding inhibitor-derived peptides induce intracellular calcium changes and modulate human neutrophil function. J Leukoc Biol. 2000, 67: 637-643. Cosentino M, Marino F, Cattaneo S, Di Grazia L, Francioli C, Fietta AM, Lecchini S, Frigo G: Diazepam-binding inhibitor-derived peptides induce intracellular calcium changes and modulate human neutrophil function. J Leukoc Biol. 2000, 67: 637-643.
17.
go back to reference Finnerty M, Marczynski TJ, Amirault HJ, Urbancic M, Andersen BR: Benzodiazepines inhibit neutrophil chemotaxis and superoxide production in a stimulus dependent manner; PK-11195 antagonizes these effects. Immunopharmacology. 1991, 22: 185-193. 10.1016/0162-3109(91)90043-X.CrossRef Finnerty M, Marczynski TJ, Amirault HJ, Urbancic M, Andersen BR: Benzodiazepines inhibit neutrophil chemotaxis and superoxide production in a stimulus dependent manner; PK-11195 antagonizes these effects. Immunopharmacology. 1991, 22: 185-193. 10.1016/0162-3109(91)90043-X.CrossRef
18.
go back to reference Ebong SJ, Call DR, Bolgos G, Newcomb DE, Granger JI, O’Reilly M, Remick DG: Immunopathologic responses to non-lethal sepsis. Shock. 1999, 12: 118-126. 10.1097/00024382-199908000-00005.CrossRef Ebong SJ, Call DR, Bolgos G, Newcomb DE, Granger JI, O’Reilly M, Remick DG: Immunopathologic responses to non-lethal sepsis. Shock. 1999, 12: 118-126. 10.1097/00024382-199908000-00005.CrossRef
19.
go back to reference Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, Opal SM, Vincent JL, Ramsay G, the International Sepsis Definitions Conference: SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med. 2001, 2003 (31): 1250-1256. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, Opal SM, Vincent JL, Ramsay G, the International Sepsis Definitions Conference: SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med. 2001, 2003 (31): 1250-1256.
20.
go back to reference Vaudry H, Tonon MC, Delarue C, Vaillant R, Kraicer J: Biological and radioimmunological evidence for melanocyte stimulating hormones (MSH) of extrapituitary origin in the rat brain. Neuroendocrinology. 1978, 27: 9-24. 10.1159/000122796.CrossRef Vaudry H, Tonon MC, Delarue C, Vaillant R, Kraicer J: Biological and radioimmunological evidence for melanocyte stimulating hormones (MSH) of extrapituitary origin in the rat brain. Neuroendocrinology. 1978, 27: 9-24. 10.1159/000122796.CrossRef
21.
go back to reference Patte C, Gandolfo P, Leprince J, Thoumas JL, Fontaine M, Vaudry H, Tonon MC: GABA inhibits endozepine release from cultured rat astrocytes. Glia. 1999, 25: 404-411. 10.1002/(SICI)1098-1136(19990215)25:4<404::AID-GLIA9>3.0.CO;2-Q.CrossRef Patte C, Gandolfo P, Leprince J, Thoumas JL, Fontaine M, Vaudry H, Tonon MC: GABA inhibits endozepine release from cultured rat astrocytes. Glia. 1999, 25: 404-411. 10.1002/(SICI)1098-1136(19990215)25:4<404::AID-GLIA9>3.0.CO;2-Q.CrossRef
22.
go back to reference Duparc C, Lefebvre H, Tonon MC, Vaudry H, Kuhn JM: Characterization of endozepines in the human testicular tissue: effect of triakontatetraneuropeptide on testosterone secretion. J Clin Endocrinol Metab. 2003, 88: 5521-5528. 10.1210/jc.2003-030783.CrossRef Duparc C, Lefebvre H, Tonon MC, Vaudry H, Kuhn JM: Characterization of endozepines in the human testicular tissue: effect of triakontatetraneuropeptide on testosterone secretion. J Clin Endocrinol Metab. 2003, 88: 5521-5528. 10.1210/jc.2003-030783.CrossRef
23.
go back to reference Matsumoto T, Ogata M, Koga K, Shigematsu A: Effect of peripheral benzodiazepine receptor ligands on lipopolysaccharide-induced tumor necrosis factor activity in thioglycolate-treated mice. Antimicrob Agents Chemother. 1994, 38: 812-816. 10.1128/AAC.38.4.812.CrossRef Matsumoto T, Ogata M, Koga K, Shigematsu A: Effect of peripheral benzodiazepine receptor ligands on lipopolysaccharide-induced tumor necrosis factor activity in thioglycolate-treated mice. Antimicrob Agents Chemother. 1994, 38: 812-816. 10.1128/AAC.38.4.812.CrossRef
24.
go back to reference Ohta N, Ohashi Y, Takayama C, Mashimo T, Fujino Y: Midazolam suppresses maturation of murine dendritic cells and priming of lipopolysaccharide-induced T helper 1-type immune response. Anesthesiology. 2011, 114: 355-362. 10.1097/ALN.0b013e3182070c1f.CrossRef Ohta N, Ohashi Y, Takayama C, Mashimo T, Fujino Y: Midazolam suppresses maturation of murine dendritic cells and priming of lipopolysaccharide-induced T helper 1-type immune response. Anesthesiology. 2011, 114: 355-362. 10.1097/ALN.0b013e3182070c1f.CrossRef
25.
go back to reference Fraser GL, Devlin JW, Worby CP, Alhazzani W, Barr J, Dasta JF, Kress JP, Davidson JE, Spencer FA: Benzodiazepine versus nonbenzodiazepine-based sedation for mechanically ventilated, critically ill adults: a systematic review and meta-analysis of randomized trials. Crit Care Med. 2013, 41 (ᅟ): S30-S38. 10.1097/CCM.0b013e3182a16898.CrossRef Fraser GL, Devlin JW, Worby CP, Alhazzani W, Barr J, Dasta JF, Kress JP, Davidson JE, Spencer FA: Benzodiazepine versus nonbenzodiazepine-based sedation for mechanically ventilated, critically ill adults: a systematic review and meta-analysis of randomized trials. Crit Care Med. 2013, 41 (ᅟ): S30-S38. 10.1097/CCM.0b013e3182a16898.CrossRef
26.
go back to reference Ferrarese C, Cogliati T, Tortorella R, Zucca C, Bogliun G, Beghi E, Passoni D, Zoia C, Begni B, Airoldi L, Alho H, Frattola L: Diazepam binding inhibitor (DBI) in the plasma of pediatric and adult epileptic patients. Epilepsy Res. 1998, 29: 129-134. 10.1016/S0920-1211(97)00074-0.CrossRef Ferrarese C, Cogliati T, Tortorella R, Zucca C, Bogliun G, Beghi E, Passoni D, Zoia C, Begni B, Airoldi L, Alho H, Frattola L: Diazepam binding inhibitor (DBI) in the plasma of pediatric and adult epileptic patients. Epilepsy Res. 1998, 29: 129-134. 10.1016/S0920-1211(97)00074-0.CrossRef
27.
go back to reference Ball JA, Ghatei MA, Sekiya K, Krausz T, Bloom SR: Diazepam binding inhibitor-like immunoreactivity(51–70): distribution in human brain, spinal cord and peripheral tissues. Brain Res. 1989, 479: 300-305. 10.1016/0006-8993(89)91632-6.CrossRef Ball JA, Ghatei MA, Sekiya K, Krausz T, Bloom SR: Diazepam binding inhibitor-like immunoreactivity(51–70): distribution in human brain, spinal cord and peripheral tissues. Brain Res. 1989, 479: 300-305. 10.1016/0006-8993(89)91632-6.CrossRef
28.
go back to reference Mocchetti I, Santi MR: Diazepam binding inhibitor peptide: cloning and gene expression. Neuropharmacology. 1991, 30: 1365-1371. 10.1016/S0028-3908(11)80003-1.CrossRef Mocchetti I, Santi MR: Diazepam binding inhibitor peptide: cloning and gene expression. Neuropharmacology. 1991, 30: 1365-1371. 10.1016/S0028-3908(11)80003-1.CrossRef
29.
go back to reference Lanfray D, Arthaud S, Ouellet J, Compère V, Do Rego JL, Leprince J, Lefranc B, Castel H, Bouchard C, Monge-Roffarello B, Richard D, Pelletier G, Vaudry H, Tonon MC, Morin F: Gliotransmission and brain glucose sensing: critical role of endozepines. Diabetes. 2013, 62: 801-810. 10.2337/db11-0785.CrossRef Lanfray D, Arthaud S, Ouellet J, Compère V, Do Rego JL, Leprince J, Lefranc B, Castel H, Bouchard C, Monge-Roffarello B, Richard D, Pelletier G, Vaudry H, Tonon MC, Morin F: Gliotransmission and brain glucose sensing: critical role of endozepines. Diabetes. 2013, 62: 801-810. 10.2337/db11-0785.CrossRef
30.
go back to reference Li Y, Hao Y, Owyang C: Diazepam-binding inhibitor mediates feedback regulation of pancreatic secretion and postprandial release of cholecystokinin. J Clin Invest. 2000, 105: 351-359. 10.1172/JCI7204.CrossRef Li Y, Hao Y, Owyang C: Diazepam-binding inhibitor mediates feedback regulation of pancreatic secretion and postprandial release of cholecystokinin. J Clin Invest. 2000, 105: 351-359. 10.1172/JCI7204.CrossRef
31.
go back to reference Van Deuren M: Kinetics of tumour necrosis factor-α, soluble tumour necrosis factor receptors, interleukin 1-β and its receptor antagonist during serious infections. Eur J Clin Microbiol Infect Dis. 1994, 13 (Suppl 1): S12-S16. 10.1007/BF02390680.CrossRef Van Deuren M: Kinetics of tumour necrosis factor-α, soluble tumour necrosis factor receptors, interleukin 1-β and its receptor antagonist during serious infections. Eur J Clin Microbiol Infect Dis. 1994, 13 (Suppl 1): S12-S16. 10.1007/BF02390680.CrossRef
32.
go back to reference Riché FC, Cholley BP, Panis YH, Laisné MJ, Briard CG, Graulet AM, Guéris JL, Valleur PD: Inflammatory cytokine response in patients with septic shock secondary to generalized peritonitis. Crit Care Med. 2000, 28: 433-437. 10.1097/00003246-200002000-00024.CrossRef Riché FC, Cholley BP, Panis YH, Laisné MJ, Briard CG, Graulet AM, Guéris JL, Valleur PD: Inflammatory cytokine response in patients with septic shock secondary to generalized peritonitis. Crit Care Med. 2000, 28: 433-437. 10.1097/00003246-200002000-00024.CrossRef
33.
go back to reference Taupin V, Gogusev J, Descamps-Latscha B, Zavala F: Modulation of tumor necrosis factor-α, interleukin-1 β, interleukin-6, interleukin-8, and granulocyte/macrophage colony-stimulating factor expression in human monocytes by an endogenous anxiogenic benzodiazepine ligand, triakontatetraneuropeptide: evidence for a role of prostaglandins. Mol Pharmacol. 1993, 43: 64-69. Taupin V, Gogusev J, Descamps-Latscha B, Zavala F: Modulation of tumor necrosis factor-α, interleukin-1 β, interleukin-6, interleukin-8, and granulocyte/macrophage colony-stimulating factor expression in human monocytes by an endogenous anxiogenic benzodiazepine ligand, triakontatetraneuropeptide: evidence for a role of prostaglandins. Mol Pharmacol. 1993, 43: 64-69.
34.
go back to reference Gavish M, Bachman I, Shoukrun R, Katz Y, Veenman L, Weisinger G, Weizman A: Enigma of the peripheral benzodiazepine receptor. Pharmacol Rev. 1999, 51: 629-650. Gavish M, Bachman I, Shoukrun R, Katz Y, Veenman L, Weisinger G, Weizman A: Enigma of the peripheral benzodiazepine receptor. Pharmacol Rev. 1999, 51: 629-650.
35.
go back to reference De Mateos-Verchere JG, Leprince J, Tonon MC, Vaudry H, Costentin J: The octadecaneuropeptide [diazepam-binding inhibitor (33–50)] exerts potent anorexigenic effects in rodents. Eur J Pharmacol. 2001, 414: 225-231. 10.1016/S0014-2999(01)00771-3.CrossRef De Mateos-Verchere JG, Leprince J, Tonon MC, Vaudry H, Costentin J: The octadecaneuropeptide [diazepam-binding inhibitor (33–50)] exerts potent anorexigenic effects in rodents. Eur J Pharmacol. 2001, 414: 225-231. 10.1016/S0014-2999(01)00771-3.CrossRef
36.
go back to reference do Rego JC, Orta MH, Leprince J, Tonon MC, Vaudry H, Costentin J: Pharmacological characterization of the receptor mediating the anorexigenic action of the octadecaneuropeptide: evidence for an endozepinergic tone regulating food intake. Neuropsychopharmacology. 2007, 32: 1641-1648. 10.1038/sj.npp.1301280.CrossRef do Rego JC, Orta MH, Leprince J, Tonon MC, Vaudry H, Costentin J: Pharmacological characterization of the receptor mediating the anorexigenic action of the octadecaneuropeptide: evidence for an endozepinergic tone regulating food intake. Neuropsychopharmacology. 2007, 32: 1641-1648. 10.1038/sj.npp.1301280.CrossRef
37.
go back to reference Borboni P, Condorelli L, De Stefanis P, Sesti G, Lauro R: Modulation of insulin secretion by diazepam binding inhibitor and its processing products. Neuropharmacology. 1991, 30: 1399-1403. 10.1016/S0028-3908(11)80008-0.CrossRef Borboni P, Condorelli L, De Stefanis P, Sesti G, Lauro R: Modulation of insulin secretion by diazepam binding inhibitor and its processing products. Neuropharmacology. 1991, 30: 1399-1403. 10.1016/S0028-3908(11)80008-0.CrossRef
38.
go back to reference Simon L, Gauvin F, Amre DK, Saint-Louis P, Lacroix J: Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. Clin Infect Dis. 2004, 39: 206-217. 10.1086/421997.CrossRef Simon L, Gauvin F, Amre DK, Saint-Louis P, Lacroix J: Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. Clin Infect Dis. 2004, 39: 206-217. 10.1086/421997.CrossRef
39.
go back to reference Uzzan B, Cohen R, Nicolas P, Cucherat M, Perret G-Y: Procalcitonin as a diagnostic test for sepsis in critically ill adults and after surgery or trauma: a systematic review and meta-analysis. Crit Care Med. 2006, 34: 1996-2003. 10.1097/01.CCM.0000226413.54364.36.CrossRef Uzzan B, Cohen R, Nicolas P, Cucherat M, Perret G-Y: Procalcitonin as a diagnostic test for sepsis in critically ill adults and after surgery or trauma: a systematic review and meta-analysis. Crit Care Med. 2006, 34: 1996-2003. 10.1097/01.CCM.0000226413.54364.36.CrossRef
40.
go back to reference Tsukagoshi E, Kawaguchi M, Shinomiya T, Yoshikawa M, Kawano T, Okubo M, Sawaki K: Diazepam enhances production of diazepam-binding inhibitor (DBI), a negative saliva secretion regulator, localized in rat salivary gland. J Pharmacol Sci. 2011, 115: 221-229. 10.1254/jphs.10282FP.CrossRef Tsukagoshi E, Kawaguchi M, Shinomiya T, Yoshikawa M, Kawano T, Okubo M, Sawaki K: Diazepam enhances production of diazepam-binding inhibitor (DBI), a negative saliva secretion regulator, localized in rat salivary gland. J Pharmacol Sci. 2011, 115: 221-229. 10.1254/jphs.10282FP.CrossRef
Metadata
Title
Increased plasma levels of endozepines, endogenous ligands of benzodiazepine receptors, during systemic inflammation: a prospective observational study
Authors
Thomas Clavier
Marie-Christine Tonon
Anne Foutel
Emmanuel Besnier
Antoine Lefevre-Scelles
Fabrice Morin
Pierrick Gandolfo
Jean-Jacques Tuech
Muriel Quillard
Benoit Veber
Bertrand Dureuil
Hélène Castel
Vincent Compère
Publication date
01-12-2014
Publisher
BioMed Central
Published in
Critical Care / Issue 6/2014
Electronic ISSN: 1364-8535
DOI
https://doi.org/10.1186/s13054-014-0633-7

Other articles of this Issue 6/2014

Critical Care 6/2014 Go to the issue